Axelar has a total of 92 patents globally, out of which 29 have been granted. Of these 92 patents, 10% patents are active. Europe is where Axelar has filed the maximum number of patents, followed by United States Of America and Japan. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Axelar.
Axelar was founded in 2003. Axelar operates as a drug development company. The Company offers anti-cancer medications to small-molecule compounds that inhibit the insulin-like growth factor-1 (IGF-1) receptor for treatment of IGF-1 receptor-dependent diseases.
Do read about some of the most popular patents of Axelar which have been covered by us in this article and also you can find Axelar patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Axelar patent portfolio.
How many patents does the CEO of Axelar have?
The CEO, Carl Harald Janson has 0 patents.
How many patents does Axelar have?
Axelar has a total of 92 patents globally. These patents belong to 10 unique patent families. Out of 92 patents, 10 patents are active.
How Many Patents did Axelar File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Axelar Applications Filed | Axelar Patents Granted |
2010 | 2 | 2 |
2011 | 28 | 1 |
2012 | – | 1 |
2013 | 8 | 1 |
2014 | 1 | 3 |
2015 | – | 1 |
2016 | – | 2 |
2017 | – | 4 |
2018 | 1 | 1 |
How many Axelar patents are Alive/Dead?
Worldwide Patents
How Many Patents did Axelar File in Different Countries?
Countries in which Axelar Filed Patents
Country | Patents |
Europe | 12 |
United States Of America | 12 |
Japan | 8 |
China | 8 |
Australia | 7 |
Canada | 7 |
Korea (South) | 5 |
Hong Kong (S.A.R.) | 3 |
Germany | 2 |
New Zealand | 2 |
Israel | 2 |
Norway | 2 |
India | 2 |
Singapore | 1 |
Spain | 1 |
Brazil | 1 |
Mexico | 1 |
Russia | 1 |
Chile | 1 |
Austria | 1 |
Denmark | 1 |
Poland | 1 |
Portugal | 1 |
Where are Research Centers of Axelar Patents Located?
10 Best Axelar Patents
WO2002102805A1 is the most popular patent in the Axelar portfolio. It has received 60 citations so far from companies like Biovitrum Ab and Osi Pharmaceuticals.
Below is the list of 10 most cited patents of Axelar:
Publication Number | Ciatation Count |
WO2002102805A1 | 60 |
US20100227797A1 | 52 |
WO2007097707A1 | 27 |
US7348358B2 | 16 |
US7662851B2 | 11 |
US20070123491A1 | 11 |
US7629381B2 | 10 |
CN101389326A | 8 |
US20040167208A1 | 7 |
US20130331445A1 | 6 |
What Percentage of Axelar US Patent Applications were Granted?
Axelar (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 37.50%.
Below are the key stats of Axelar patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Axelar?
Law Firm | Total Applications | Success Rate |
Gtc Law Group | 56 | 89.66% |
Tina M Lessani | 2 | 100.00% |
David Newman | 1 | 100.00% |
Fox Rothschild | 1 | 100.00% |
Grayrobinson | 1 | 100.00% |
Logical Semantics | 1 | 100.00% |
Pierce Atwood | 1 | 100.00% |
Platinum Intellectual Property | 1 | 0% |
EXCLUSIVE INSIGHTS COMING SOON!